Robert Strayer

Rob Strayer serves as the Executive Vice President of Policy at the Information Technology Industry Council (ITI). He leads ITI’s efforts to shape technology policy around the world to enable innovation, competition, and economic growth, while supporting governments efforts to achieve their public policy objectives. Managing a team of experienced professionals at ITI, he is responsible for developing and executing policy strategies in major global markets and on a wide range of digital technology issues, including privacy and data protection, cybersecurity, trade and market access, taxation, artificial intelligence, and standards.

Prior to joining ITI, Strayer served as the Deputy Assistant Secretary of State for Cyber and International Communications Policy at the U.S. State Department. In that role, he led dozens of bilateral and multilateral dialogues with foreign governments on digital economy regulatory, cybersecurity, and technology supply chain security issues. He was named as an ambassador by the President to lead the 90-plus person U.S. delegation to the International Telecommunication Union (ITU) Plenipotentiary Conference in Dubai, United Arab Emirates in 2018.

Before joining the State Department, Strayer was the general counsel for the U.S. Senate Foreign Relations Committee. He also practiced telecommunications law at WilmerHale, and clerked for the U.S. Court of Appeals for the Eleventh Circuit.

Strayer received a law degree from Vanderbilt University Law School, and earned his B.A. in Economics, summa cum laude, from Denison University.

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent
Read More

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More